 | • レポートコード：MRC2012A3012 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、喘息・COPD治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。喘息・COPD治療薬の種類別市場規模（ジェネリック医薬品、特許医薬品）、用途別市場規模（喘息、COPD）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Teva、Abbott、Novartis、Roche、Merck、Pfizer、AstraZeneca、Boehringer Ingelheim、Vectura、Apotex、Mylan、Akorn、Allergan、Cipla、 ・地域別グローバル市場分析 2015年-2020年 ・喘息・COPD治療薬の北米市場（アメリカ、カナダ、メキシコ） ・喘息・COPD治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・喘息・COPD治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・喘息・COPD治療薬の南米市場（ブラジル、アルゼンチン） ・喘息・COPD治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ジェネリック医薬品、特許医薬品 ・用途別分析：喘息、COPD ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Drugs for Asthma and COPD market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Drugs for Asthma and COPD market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Drugs for Asthma and COPD market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drugs for Asthma and COPD market has been segmented into
Generic Drugs
Patented Drugs
By Application, Drugs for Asthma and COPD has been segmented into:
Asthma
COPD
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs for Asthma and COPD market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs for Asthma and COPD markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs for Asthma and COPD market.
The report offers in-depth assessment of the growth and other aspects of the Drugs for Asthma and COPD market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Drugs for Asthma and COPD Market Share Analysis
Drugs for Asthma and COPD competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs for Asthma and COPD sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs for Asthma and COPD sales, revenue and market share for each player covered in this report.
The major players covered in Drugs for Asthma and COPD are:
GSK
Teva
Abbott
Novartis
Roche
Merck
Pfizer
AstraZeneca
Boehringer Ingelheim
Vectura
Apotex
Mylan
Akorn
Allergan
Cipla
Among other players domestic and global, Drugs for Asthma and COPD market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Asthma and COPD product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Asthma and COPD, with price, sales, revenue and global market share of Drugs for Asthma and COPD in 2018 and 2019.
Chapter 3, the Drugs for Asthma and COPD competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Asthma and COPD breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Drugs for Asthma and COPD market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Drugs for Asthma and COPD sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Drugs for Asthma and COPD Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Asthma and COPD Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Generic Drugs
1.2.3 Patented Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Asthma and COPD Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Asthma
1.3.3 COPD
1.4 Overview of Global Drugs for Asthma and COPD Market
1.4.1 Global Drugs for Asthma and COPD Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teva SWOT Analysis
2.2.4 Teva Product and Services
2.2.5 Teva Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abbott SWOT Analysis
2.3.4 Abbott Product and Services
2.3.5 Abbott Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Vectura
2.10.1 Vectura Details
2.10.2 Vectura Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Vectura SWOT Analysis
2.10.4 Vectura Product and Services
2.10.5 Vectura Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Apotex
2.11.1 Apotex Details
2.11.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Apotex SWOT Analysis
2.11.4 Apotex Product and Services
2.11.5 Apotex Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Mylan
2.12.1 Mylan Details
2.12.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Mylan SWOT Analysis
2.12.4 Mylan Product and Services
2.12.5 Mylan Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Akorn
2.13.1 Akorn Details
2.13.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Akorn SWOT Analysis
2.13.4 Akorn Product and Services
2.13.5 Akorn Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Allergan
2.14.1 Allergan Details
2.14.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Allergan SWOT Analysis
2.14.4 Allergan Product and Services
2.14.5 Allergan Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Cipla
2.15.1 Cipla Details
2.15.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Cipla SWOT Analysis
2.15.4 Cipla Product and Services
2.15.5 Cipla Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Drugs for Asthma and COPD Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Drugs for Asthma and COPD Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Drugs for Asthma and COPD Manufacturer Market Share in 2019
3.3.2 Top 6 Drugs for Asthma and COPD Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Drugs for Asthma and COPD Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Asthma and COPD Sales and Market Share by Regions (2015-2020)
4.1.2 Global Drugs for Asthma and COPD Revenue and Market Share by Regions (2015-2020)
4.2 North America Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
4.3 Europe Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
4.5 South America Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Drugs for Asthma and COPD Sales, Revenue and Market Share by Country
5.1.1 North America Drugs for Asthma and COPD Sales and Market Share by Country (2015-2020)
5.1.2 North America Drugs for Asthma and COPD Revenue and Market Share by Country (2015-2020)
5.2 United States Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
5.3 Canada Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
5.4 Mexico Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Drugs for Asthma and COPD Sales, Revenue and Market Share by Country
6.1.1 Europe Drugs for Asthma and COPD Sales and Market Share by Country (2015-2020)
6.1.2 Europe Drugs for Asthma and COPD Revenue and Market Share by Country (2015-2020)
6.2 Germany Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
6.3 UK Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
6.4 France Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
6.5 Russia Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
6.6 Italy Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Drugs for Asthma and COPD Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Drugs for Asthma and COPD Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Drugs for Asthma and COPD Revenue and Market Share by Regions (2015-2020)
7.2 China Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
7.3 Japan Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
7.4 Korea Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
7.5 India Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
7.7 Australia Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Drugs for Asthma and COPD Sales, Revenue and Market Share by Country
8.1.1 South America Drugs for Asthma and COPD Sales and Market Share by Country (2015-2020)
8.1.2 South America Drugs for Asthma and COPD Revenue and Market Share by Country (2015-2020)
8.2 Brazil Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
8.3 Argentina Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Drugs for Asthma and COPD Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Drugs for Asthma and COPD Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Drugs for Asthma and COPD Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
9.3 Turkey Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
9.4 Egypt Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
9.5 South Africa Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Drugs for Asthma and COPD Sales and Market Share by Type (2015-2020)
10.2 Global Drugs for Asthma and COPD Revenue and Market Share by Type (2015-2020)
10.3 Global Drugs for Asthma and COPD Price by Type (2015-2020)
11 Global Drugs for Asthma and COPD Market Segment by Application
11.1 Global Drugs for Asthma and COPD Sales Market Share by Application (2015-2020)
11.2 Global Drugs for Asthma and COPD Revenue Market Share by Application (2015-2020)
11.3 Global Drugs for Asthma and COPD Price by Application (2015-2020)
12 Market Forecast
12.1 Global Drugs for Asthma and COPD Sales, Revenue and Growth Rate (2021-2025)
12.2 Drugs for Asthma and COPD Market Forecast by Regions (2021-2025)
12.2.1 North America Drugs for Asthma and COPD Market Forecast (2021-2025)
12.2.2 Europe Drugs for Asthma and COPD Market Forecast (2021-2025)
12.2.3 Asia-Pacific Drugs for Asthma and COPD Market Forecast (2021-2025)
12.2.4 South America Drugs for Asthma and COPD Market Forecast (2021-2025)
12.2.5 Middle East & Africa Drugs for Asthma and COPD Market Forecast (2021-2025)
12.3 Drugs for Asthma and COPD Market Forecast by Type (2021-2025)
12.3.1 Global Drugs for Asthma and COPD Sales Forecast by Type (2021-2025)
12.3.2 Global Drugs for Asthma and COPD Market Share Forecast by Type (2021-2025)
12.4 Drugs for Asthma and COPD Market Forecast by Application (2021-2025)
12.4.1 Global Drugs for Asthma and COPD Sales Forecast by Application (2021-2025)
12.4.2 Global Drugs for Asthma and COPD Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Drugs for Asthma and COPD Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs for Asthma and COPD by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs for Asthma and COPD Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Drugs for Asthma and COPD Major Business
Table 9. GSK Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 10. GSK SWOT Analysis
Table 11. GSK Drugs for Asthma and COPD Product and Services
Table 12. GSK Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Teva Basic Information, Manufacturing Base and Competitors
Table 14. Teva Drugs for Asthma and COPD Major Business
Table 15. Teva Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 16. Teva SWOT Analysis
Table 17. Teva Drugs for Asthma and COPD Product and Services
Table 18. Teva Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Abbott Basic Information, Manufacturing Base and Competitors
Table 20. Abbott Drugs for Asthma and COPD Major Business
Table 21. Abbott Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 22. Abbott SWOT Analysis
Table 23. Abbott Drugs for Asthma and COPD Product and Services
Table 24. Abbott Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis Drugs for Asthma and COPD Major Business
Table 27. Novartis Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 28. Novartis SWOT Analysis
Table 29. Novartis Drugs for Asthma and COPD Product and Services
Table 30. Novartis Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Drugs for Asthma and COPD Major Business
Table 33. Roche Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 34. Roche SWOT Analysis
Table 35. Roche Drugs for Asthma and COPD Product and Services
Table 36. Roche Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck Drugs for Asthma and COPD Major Business
Table 39. Merck Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck Drugs for Asthma and COPD Product and Services
Table 42. Merck Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Pfizer Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Drugs for Asthma and COPD Major Business
Table 45. Pfizer Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 46. Pfizer SWOT Analysis
Table 47. Pfizer Drugs for Asthma and COPD Product and Services
Table 48. Pfizer Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 50. AstraZeneca Drugs for Asthma and COPD Major Business
Table 51. AstraZeneca Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 52. AstraZeneca SWOT Analysis
Table 53. AstraZeneca Drugs for Asthma and COPD Product and Services
Table 54. AstraZeneca Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 56. Boehringer Ingelheim Drugs for Asthma and COPD Major Business
Table 57. Boehringer Ingelheim Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 58. Boehringer Ingelheim SWOT Analysis
Table 59. Boehringer Ingelheim Drugs for Asthma and COPD Product and Services
Table 60. Boehringer Ingelheim Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Vectura Basic Information, Manufacturing Base and Competitors
Table 62. Vectura Drugs for Asthma and COPD Major Business
Table 63. Vectura Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 64. Vectura SWOT Analysis
Table 65. Vectura Drugs for Asthma and COPD Product and Services
Table 66. Vectura Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Apotex Basic Information, Manufacturing Base and Competitors
Table 68. Apotex Drugs for Asthma and COPD Major Business
Table 69. Apotex Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 70. Apotex SWOT Analysis
Table 71. Apotex Drugs for Asthma and COPD Product and Services
Table 72. Apotex Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Mylan Basic Information, Manufacturing Base and Competitors
Table 74. Mylan Drugs for Asthma and COPD Major Business
Table 75. Mylan Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 76. Mylan SWOT Analysis
Table 77. Mylan Drugs for Asthma and COPD Product and Services
Table 78. Mylan Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Akorn Basic Information, Manufacturing Base and Competitors
Table 80. Akorn Drugs for Asthma and COPD Major Business
Table 81. Akorn Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 82. Akorn SWOT Analysis
Table 83. Akorn Drugs for Asthma and COPD Product and Services
Table 84. Akorn Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Allergan Basic Information, Manufacturing Base and Competitors
Table 86. Allergan Drugs for Asthma and COPD Major Business
Table 87. Allergan Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 88. Allergan SWOT Analysis
Table 89. Allergan Drugs for Asthma and COPD Product and Services
Table 90. Allergan Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Cipla Basic Information, Manufacturing Base and Competitors
Table 92. Cipla Drugs for Asthma and COPD Major Business
Table 93. Cipla Drugs for Asthma and COPD Total Revenue (USD Million) (2017-2018)
Table 94. Cipla SWOT Analysis
Table 95. Cipla Drugs for Asthma and COPD Product and Services
Table 96. Cipla Drugs for Asthma and COPD Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Drugs for Asthma and COPD Sales by Manufacturer (2018-2019) (MT)
Table 98. Global Drugs for Asthma and COPD Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Drugs for Asthma and COPD Sales by Regions (2015-2020) (MT)
Table 100. Global Drugs for Asthma and COPD Sales Market Share by Regions (2015-2020)
Table 101. Global Drugs for Asthma and COPD Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Drugs for Asthma and COPD Sales by Countries (2015-2020) (MT)
Table 103. North America Drugs for Asthma and COPD Sales Market Share by Countries (2015-2020)
Table 104. North America Drugs for Asthma and COPD Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Drugs for Asthma and COPD Revenue Market Share by Countries (2015-2020)
Table 106. Europe Drugs for Asthma and COPD Sales by Countries (2015-2020) (MT)
Table 107. Europe Drugs for Asthma and COPD Sales Market Share by Countries (2015-2020)
Table 108. Europe Drugs for Asthma and COPD Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Drugs for Asthma and COPD Sales by Regions (2015-2020) (MT)
Table 110. Asia-Pacific Drugs for Asthma and COPD Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Drugs for Asthma and COPD Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Drugs for Asthma and COPD Sales by Countries (2015-2020) (MT)
Table 113. South America Drugs for Asthma and COPD Sales Market Share by Countries (2015-2020)
Table 114. South America Drugs for Asthma and COPD Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Drugs for Asthma and COPD Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Drugs for Asthma and COPD Sales by Countries (2015-2020) (MT)
Table 117. Middle East & Africa Drugs for Asthma and COPD Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Drugs for Asthma and COPD Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Drugs for Asthma and COPD Revenue Market Share by Countries (2015-2020)
Table 120. Global Drugs for Asthma and COPD Sales by Type (2015-2020) (MT)
Table 121. Global Drugs for Asthma and COPD Sales Share by Type (2015-2020)
Table 122. Global Drugs for Asthma and COPD Revenue by Type (2015-2020) (USD Million)
Table 123. Global Drugs for Asthma and COPD Revenue Share by Type (2015-2020)
Table 124. Global Drugs for Asthma and COPD Sales by Application (2015-2020) (MT)
Table 125. Global Drugs for Asthma and COPD Sales Share by Application (2015-2020)
Table 126. Global Drugs for Asthma and COPD Sales Forecast by Regions (2021-2025) (MT)
Table 127. Global Drugs for Asthma and COPD Market Share Forecast by Regions (2021-2025)
Table 128. Global Drugs for Asthma and COPD Sales Forecast by Type (2021-2025) (MT)
Table 129. Global Drugs for Asthma and COPD Market Share Forecast by Type (2021-2025)
Table 130. Global Drugs for Asthma and COPD Sales Forecast by Application (2021-2025)
Table 131. Global Drugs for Asthma and COPD Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Drugs for Asthma and COPD Picture
Figure 2. Global Sales Market Share of Drugs for Asthma and COPD by Type in 2019
Figure 3. Generic Drugs Picture
Figure 4. Patented Drugs Picture
Figure 5. Drugs for Asthma and COPD Sales Market Share by Application in 2018
Figure 6. Asthma Picture
Figure 7. COPD Picture
Figure 8. Global Drugs for Asthma and COPD Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Drugs for Asthma and COPD Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Drugs for Asthma and COPD Sales Market Share by Manufacturer in 2019
Figure 29. Global Drugs for Asthma and COPD Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Drugs for Asthma and COPD Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Drugs for Asthma and COPD Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 34. Global Drugs for Asthma and COPD Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Drugs for Asthma and COPD Revenue Market Share by Regions (2015-2020)
Figure 36. Global Drugs for Asthma and COPD Revenue Market Share by Regions in 2018
Figure 37. North America Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
Figure 38. Europe Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
Figure 40. South America Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Drugs for Asthma and COPD Sales and Growth Rate (2015-2020)
Figure 42. North America Drugs for Asthma and COPD Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Drugs for Asthma and COPD Sales Market Share by Countries (2015-2020)
Figure 44. North America Drugs for Asthma and COPD Sales Market Share by Countries in 2018
Figure 45. North America Drugs for Asthma and COPD Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Drugs for Asthma and COPD Revenue Market Share by Countries in 2018
Figure 47. United States Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 48. Canada Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 49. Mexico Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 50. Europe Drugs for Asthma and COPD Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Drugs for Asthma and COPD Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Drugs for Asthma and COPD Revenue Market Share by Countries in 2019
Figure 53. Germany Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 54. UK Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 55. France Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 56. Russia Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 57. Italy Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 58. Asia-Pacific Drugs for Asthma and COPD Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Drugs for Asthma and COPD Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Drugs for Asthma and COPD Revenue Market Share by Regions 2019
Figure 61. China Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 62. Japan Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 63. Korea Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 64. India Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 65. Southeast Asia Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 66. South America Drugs for Asthma and COPD Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Drugs for Asthma and COPD Sales Market Share by Countries in 2019
Figure 68. South America Drugs for Asthma and COPD Revenue Market Share by Countries in 2019
Figure 69. Brazil Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 70. Argentina Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 71. Middle East and Africa Drugs for Asthma and COPD Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Drugs for Asthma and COPD Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Drugs for Asthma and COPD Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Drugs for Asthma and COPD Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 76. Egypt Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 77. Turkey Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 78. South Africa Drugs for Asthma and COPD Sales and Growth Rate (2015-2020) (MT)
Figure 79. Global Drugs for Asthma and COPD Sales and Growth Rate (2021-2025) (MT)
Figure 80. Global Drugs for Asthma and COPD Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Drugs for Asthma and COPD Market Forecast (2021-2025) (MT)
Figure 82. Europe Sales Drugs for Asthma and COPD Market Forecast (2021-2025) (MT)
Figure 83. Asia-Pacific Sales Drugs for Asthma and COPD Market Forecast (2021-2025) (MT)
Figure 84. South America Sales Drugs for Asthma and COPD Market Forecast (2021-2025) (MT)
Figure 85. Middle East & Africa Sales Drugs for Asthma and COPD Market Forecast (2021-2025) (MT)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
喘息・COPDの世界市場（～2026年） Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway. Asthma is usually considered a sepa…- COPD薬剤の世界市場（～2026年） COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors， steroids, combination therapies, etc. One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to tre…
- 喘息薬の世界市場（～2026年） Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell …
- 喘息治療薬の世界市場（～2026年） Market Analysis and Insights: Global Asthma Treatment Drugs Market The global Asthma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Asthma Treatment Drugs Scope and Market Size Asthma Treatment Drugs m…
- 好酸球性喘息治療の世界市場（～2026年） Eosinophilic asthma is a form of asthma categorized by greater levels of eosinophils in the air passages. Eosinophilic Asthma Treatment market is driven by increasing pollution and lowering immunity in the population. Susceptibility of allergies within individuals has increased resulting in the incr…